China Universal Asset Management Company’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Sell
31,076
-11,169
-26% -$71.3K 0.01% 338
2026
Q1
$245K Buy
42,245
+15,208
+56% +$101K 0.02% 333
2025
Q4
$212K Sell
27,037
-1,268
-4% -$9.98K 0.02% 340
2025
Q3
$230K Sell
28,305
-3,862
-12% -$25.7K 0.02% 322
2025
Q2
$150K Buy
32,167
+2,264
+8% +$10.4K 0.01% 334
2025
Q1
$164K Sell
29,903
-1,708
-5% -$6.89K 0.02% 327
2024
Q4
$107K Buy
31,611
+2,954
+10% +$9.5K 0.01% 384
2024
Q3
$81.7K Buy
28,657
+11,239
+65% +$28.9K 0.01% 369
2024
Q2
$39.2K Sell
17,418
-9,098
-34% -$18.3K 0.01% 371
2024
Q1
$58.6K Buy
26,516
+10,543
+66% +$27.3K 0.01% 407
2023
Q4
$37.5K Buy
15,973
+12,432
+351% +$22.9K 0.01% 393
2023
Q3
$6.59K Buy
3,541
+1,742
+97% +$3.99K ﹤0.01% 371
2023
Q2
$4.71K Sell
1,799
-43
-2% -$109 ﹤0.01% 377
2023
Q1
$3K Buy
1,842
+461
+33% +$577 ﹤0.01% 412
2022
Q4
$1.84K Buy
1,381
+108
+8% +$152 ﹤0.01% 378
2022
Q3
$2K Buy
+1,273
New +$2.1K ﹤0.01% 362

Other funds holding XERS

China Universal Asset Management Company's XERS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Xeris Biopharma Holdings (XERS) stake by 26% in Q2 2026, selling an estimated $71.3K and leaving 31,076 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #338.

China Universal Asset Management Company first reported a position in XERS in Q3 2022 and has held it in 16 quarters since. 35 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • China Universal Asset Management Company held 31,076 shares of Xeris Biopharma Holdings worth $246K as of Q2 2026.
  • China Universal Asset Management Company sold 11,169 Xeris Biopharma Holdings shares in Q2 2026, an estimated $71.3K.
  • Xeris Biopharma Holdings made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #338 holding.
  • China Universal Asset Management Company first reported a position in Xeris Biopharma Holdings in Q3 2022 and has held it in 16 quarters since.
  • 35 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.